Rafał Pawliczak Selected Research

Rafał Pawliczak Research Topics

Disease

12	Asthma (Bronchial Asthma) 11/2023 - 01/2007
6	Atopic Dermatitis (Atopic Eczema) 11/2023 - 01/2009
5	Inflammation (Inflammations) 12/2018 - 06/2003
4	COVID-19 10/2023 - 01/2021
3	Neoplasms (Cancer) 11/2023 - 01/2009
3	Allergic Rhinitis 07/2023 - 01/2009
2	Infections 10/2023 - 07/2022
2	Airway Remodeling 10/2022 - 01/2007
2	Blister (Bulla) 01/2017 - 01/2009
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2023
1	Obesity 10/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Atherosclerosis 01/2021
1	Disease Progression 10/2020
1	Burns 02/2020
1	Respiratory Hypersensitivity 10/2017
1	Hypersensitivity (Allergy) 12/2016
1	Aspirin-Induced Asthma 06/2015
1	Urticaria (Hives) 01/2009
1	Dermatitis Herpetiformis (Disease, Duhring's) 01/2009
1	Bullous Pemphigoid (Pemphigoid) 01/2009
1	Autoimmune Diseases (Autoimmune Disease) 01/2009
1	Insulin Resistance 01/2005
1	Bacteremia 12/2003

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 11/2023 - 01/2017
3	AntioxidantsIBA 11/2023 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2023 - 06/2003
2	dupilumabIBA 10/2023 - 01/2021
2	Histamine Antagonists (Antihistamines)IBA 07/2023 - 12/2016
2	COVID-19 VaccinesIBA 07/2022 - 01/2022
2	VaccinesIBA 07/2022 - 01/2022
2	SmokeIBA 10/2020 - 02/2020
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2017 - 01/2005
2	LipidsIBA 10/2017 - 01/2009
1	Formoterol Fumarate (Oxis)FDA Link 11/2023
1	Beclomethasone (Beclometasone)FDA Link 11/2023
1	ResveratrolIBA 11/2023
1	baricitinibIBA 10/2023
1	remdesivirIBA 10/2023
1	sotrovimabIBA 10/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2023
1	Ritonavir (Norvir)FDA Link 10/2023
1	Ivermectin (Mectizan)FDA Link 10/2023
1	sarilumabIBA 10/2023
1	casirivimab and imdevimab drug combinationIBA 10/2023
1	tocilizumab (atlizumab)FDA Link 10/2023
1	Thioctic Acid (Lipoic Acid)IBA 10/2023
1	acetovanillone (apocynin)IBA 10/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 07/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 07/2023
1	AllergensIBA 07/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Calcitriol (Calcijex)FDA LinkGeneric 10/2022
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 10/2022
1	Vitamin D FDA LinkGeneric 10/2022
1	Choline (Choline Chloride)IBA 03/2022
1	Ointments (Pastes)IBA 03/2022
1	glycerylphosphoinositolIBA 03/2022
1	SaltsIBA 03/2022
1	EmollientsIBA 03/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Azathioprine (Imuran)FDA LinkGeneric 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021
1	Salmeterol Xinafoate (Serevent)FDA Link 12/2020
1	Menthol FDA Link 10/2020
1	Free RadicalsIBA 02/2020
1	NitrosaminesIBA 02/2020
1	Calcineurin InhibitorsIBA 12/2019
1	Immunologic Factors (Immunomodulators)IBA 12/2019
1	AdiponectinIBA 12/2018
1	Troglitazone (Rezulin)FDA Link 12/2017
1	Leukotriene C4IBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 10/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2015
1	Omalizumab (Xolair)FDA Link 01/2013
1	IntegrinsIBA 01/2009
1	AutoantibodiesIBA 01/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2007
1	ArginaseIBA 01/2007
1	Arginine (L-Arginine)FDA Link 01/2007
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2007
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2007
1	PPAR gammaIBA 01/2005
1	Immunoglobulins (Immunoglobulin)IBA 12/2003

Therapy/Procedure

4	Therapeutics 11/2023 - 12/2017
1	Metered Dose Inhalers (Metered Dose Inhaler) 11/2023
1	Nebulizers and Vaporizers (Inhaler) 11/2023
1	Fat-Restricted Diet (Diet, Fat Restricted) 10/2023
1	Immunotherapy 07/2023
1	Drug Therapy (Chemotherapy) 07/2023
1	Aftercare (After-Treatment) 12/2020